Article

Prophylactic Treatment of COVID-19 in Care Homes Trial (PROTECT-CH)

2022-08-31

Abstract excerpt

<h4>Background</h4> Coronavirus disease 2019 (COVID-19) is associated with significant mortality and morbidity in care homes. Novel or repurposed antiviral drugs may reduce infection and disease severity through reducing viral replication and inflammation. <h4>Objective</h4> To compare the safety and efficacy of antiviral agents (ciclesonide, niclosamide) for preventing SARS-CoV-2 infection and COVID-19 severity i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: eb70244e-9d26-568b-b243-ea2157893059
DOI: 10.1101/2022.08.29.22279359

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prophylactic Treatment of COVID-19 in Care Homes Trial (PROTECT-CH)DOI 10.1101/2022.08.29.22279359Read

A Simple, Home-Therapy Algorithm to Prevent Hospitalization for COVID-19 Patients:<i>A Retrospective Observational Matched-Cohort Study</i>Semantic proximity Read

Outpatient regimens to reduce COVID-19 hospitalisations: a systematic review and meta-analysis of randomized controlled trialsSemantic proximity Read

Preventive interventions for post Covid-19 condition: systematic review updateSemantic proximity Read

Have infection control and prevention measures resulted in any adverse outcomes for care home and domiciliary care residents and staff?Semantic proximity Read

Post-exposure Prophylaxis Against SARS-CoV-2 in Close Contacts of Confirmed COVID-19 Cases (CORIPREV): Study Protocol for a Cluster-randomised TrialSemantic proximity Read

Non-Pharmaceutical Interventions and COVID-19 Burden in the United StatesSemantic proximity Read

Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: A systematic review and meta-analysisSemantic proximity Read

PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardshipSemantic proximity Read

COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series StudySemantic proximity Read

A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19Semantic proximity Read

Resveratrol and Zinc in the Treatment of Outpatients With COVID-19 – The Reszinate Study - A Phase 1/2 Randomized Clinical Trial Utilizing Home Patient-Obtained Nasal and Saliva Viral SamplingSemantic proximity Read

Inhaled Fluticasone for Outpatient Treatment of Covid-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical TrialSemantic proximity Read